The use of immune checkpoint inhibitors in advanced gastric/gastroesophageal adenocarcinomas -- real-world evidence and the use of alternative dosing.

Autor: Dhanawat, Aditya¹, Trikha, Mehak¹, Vora, Manan¹, Gujarathi, Himanshu¹, Ostwal, Vikas¹, Bhargava, Prabhat¹, Kaushal, Rajiv¹, Ramaswamy, Anant¹ anantr13@gmail.com

Publikováno v: Ecancermedicalscience. 2024, Vol. 18 Issue 1676-1753, p1-11. 11p.

Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India.

Autor: Muddu VK; Department of Medical Oncology and Hematology, Institute of Oncology, AIG Hospitals, Hyderabad, India., Shah A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., John A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Raj A; Department of Medical Oncology, Sarvodaya Hospital, Faridabad, India., Bahl A; Department of Medical Oncology, Fortis Memorial Hospital, Gurgaon, India., Rajappa SJ; Department of Medical Oncology, Basavatarakam Indo American Cancer Hospital & RI, Hyderabad, India., Raja T; Department of Medical Oncology, Apollo Cancer Hospital, Chennai, India., Ghosh J; Department of Medical Oncology, Apollo Cancer Center, Kolkata, India., Lavingia V; Department of GI Medical Oncology, Shalby Hospital, Ahmedabad, India., Vora A; Hope Cancer Centre, New Delhi, India., Bhargava P; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Ramaswamy A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Khan A; Department of Medical Oncology and Hematology, Institute of Oncology, AIG Hospitals, Hyderabad, India., Sharma A; Department of Medical Oncology, Max Superspeciality Hospital, Delhi, India., Trikha M; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Dhanawat A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Bonda A; Department of Medical Oncology, AIG Hospitals, Hyderabad, India., Siripurapu I; Department of Medical Oncology, AIG Hospitals, Hyderabad, India., Mahajan M; Department of Medical Oncology, Pacific Medical College, Udaipur, India., Rohatgi N; Department of Medical Oncology, Fortis Memorial Hospital, Gurgaon, India., Chandrakant MV; Department of Medical Oncology, Narayana Superspeciality Hospital, Howrah and R N Tagore Hospital, Kolkata, India., Gujarathi H; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Vora M; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India., Ankathi S; Department of Interventional Radiology, Tata Memorial Centre, Homi Bhabha National Institute HBNI, Mumbai, India., Ostwal VS; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2024 Dec; Vol. 10, pp. e2400216. Date of Electronic Publication: 2024 Dec 05.